» Articles » PMID: 40032619

The Effect of Electroconvulsive and Magnetic Seizure Therapy (MST) on Cortical Thickness in Schizophrenia

Overview
Specialties Neurology
Pharmacology
Date 2025 Mar 3
PMID 40032619
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying ways to conduct brain stimulation that match the clinical efficacy of electroconvulsive therapy (ECT) without the side effects of ECT is an important goal in schizophrenia (SCS). Magnetic seizure therapy (MST) is a potential alternative, which has shown considerable efficacy but with mild cognitive impairment.

Objective: This study compared the clinical efficacy and cognitive side effects of ECT and MST. In addition, we also investigated the possible contribution of cortical thickness changes to treatment response.

Methods: Thirty-four confirmed schizophrenia patients were randomly treated with ECT (n = 16) or MST (n = 18) for 4 weeks. Mental symptoms were measured through PANSS, cognition was measured through the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and changes in cortical thickness before and after treatment were compared using FreeSurfer.

Results: Both treatments reduced the PANSS score and had comparable efficacy, while MST was superior in preserving the RBANS language score.

Conclusion: In this study, neither the MST group nor the ECT group showed significant changes in cortical thickness after treatment. MST, like ECT, effectively alleviates symptoms of schizophrenia but retains cognitive function slightly better.

Trial Registration: ClinicalTrials.gov identifier: NCT02746965.

References
1.
North H, Bruggemann J, Cropley V, Swaminathan V, Sundram S, Lenroot R . Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci. 2021; 271(4):595-607. DOI: 10.1007/s00406-021-01237-z. View

2.
Barry A, Koeppel J, Ho B . Impulsive decision making, brain cortical thickness and familial schizophrenia risk. Schizophr Res. 2020; 220:54-60. DOI: 10.1016/j.schres.2020.03.072. View

3.
Gbyl K, Rostrup E, Raghava J, Carlsen J, Schmidt L, Lindberg U . Cortical thickness following electroconvulsive therapy in patients with depression: a longitudinal MRI study. Acta Psychiatr Scand. 2019; 140(3):205-216. DOI: 10.1111/acps.13068. View

4.
Zhao Y, Zhang Q, Shah C, Li Q, Sweeney J, Li F . Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022; 79(6):560-570. PMC: 9047772. DOI: 10.1001/jamapsychiatry.2022.0799. View

5.
Rami-Gonzalez L, Bernardo M, Boget T, Salamero M, Gil-Verona J, Junque C . Subtypes of memory dysfunction associated with ECT: characteristics and neurobiological bases. J ECT. 2001; 17(2):129-35. DOI: 10.1097/00124509-200106000-00008. View